Webinar: Patient Assistance in the Wake of COVID19

As the U.S. economy continues to feel the ripple effect of the coronavirus pandemic and more Americans lose their jobs, will patients be able to afford their medications?

It’s a question that matters across therapeutic areas and one that will impact manufacturers’ commercialization strategies, especially as it relates to patient and provider support. 

Watch a panel of experts from Lash Group and Xcenda as they offer insights on:

• How the COVID-19 pandemic will impact insurance coverage
• The resulting affordability challenges patients will face
• How manufacturers can adapt their patient assistance programs to ensure access to important therapies